Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriko Nishimura

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Blood|May 20, 2017
BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluationNaoko Tsuyama, Seiji Sakata, Satoko Baba, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 9, 2017
Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphomaAnna Takahashi, Yuko Mishima, Masahiro Yokoyama, et al.
Scientific Reports|August 22, 2023
Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapyYuko Shirouchi, Noriko Nishimura, Yuko Mishima, et al.
British Journal of Haematology|October 28, 2017
Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5<sup>+</sup> DLBCLYuko Mishima, Yasuhito Terui, Masahiro Yokoyama, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2021
Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCLShoko Marshall, Noriko Nishimura, Norihito Inoue, et al.
Experimental Hematology & Oncology|December 6, 2012
R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphomaYuko Mishima, Yasuhito Terui, Masahiro Yokoyama, et al.
Journal of Cancer Research and Clinical Oncology|June 3, 2021
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of MyelomaShuji Ozaki, Hiroshi Handa, Hiromi Koiso, et al.
Clinical Journal of Gastroenterology|August 28, 2021
Pancreatic follicular lymphoma: a report of two cases and literature reviewTakeshi Okamoto, Takashi Sasaki, Noriko Nishimura, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 25, 2009
[History of the histological staining survey in the Tokyo Metropolitan Hospital]Satoshi Ichikawa, Kazuaki Enatsu, Seiko Yamane, et al.
Research Square|February 26, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple MyelomaAlexander Lesokhin, Karthik Nath, Tala Shekarkhand, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Blood|May 20, 2017
BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluationNaoko Tsuyama, Seiji Sakata, Satoko Baba, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 9, 2017
Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphomaAnna Takahashi, Yuko Mishima, Masahiro Yokoyama, et al.
Scientific Reports|August 22, 2023
Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapyYuko Shirouchi, Noriko Nishimura, Yuko Mishima, et al.
British Journal of Haematology|October 28, 2017
Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5<sup>+</sup> DLBCLYuko Mishima, Yasuhito Terui, Masahiro Yokoyama, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2021
Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCLShoko Marshall, Noriko Nishimura, Norihito Inoue, et al.
Experimental Hematology & Oncology|December 6, 2012
R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphomaYuko Mishima, Yasuhito Terui, Masahiro Yokoyama, et al.
Journal of Cancer Research and Clinical Oncology|June 3, 2021
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of MyelomaShuji Ozaki, Hiroshi Handa, Hiromi Koiso, et al.
Clinical Journal of Gastroenterology|August 28, 2021
Pancreatic follicular lymphoma: a report of two cases and literature reviewTakeshi Okamoto, Takashi Sasaki, Noriko Nishimura, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 25, 2009
[History of the histological staining survey in the Tokyo Metropolitan Hospital]Satoshi Ichikawa, Kazuaki Enatsu, Seiko Yamane, et al.
Research Square|February 26, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple MyelomaAlexander Lesokhin, Karthik Nath, Tala Shekarkhand, et al.
Pageof 9